ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2021

Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering.

Sanghwan Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.